Recommended diagnostic criteria for paraneoplastic neurological syndromes

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 8, 2004, Pages 1090-

  Greenlee, J E ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CANCER ANTIBODY;

ANTIBODY DETECTION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER REGRESSION; CANCER RISK; CEREBELLUM DEGENERATION; CLINICAL FEATURE; DISEASE CLASSIFICATION; EDITORIAL; HUMAN; NEURITIS; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL;

EID: 3442879056     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.038489     Document Type: Editorial

References (5)

1. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543-54.
2. Moll JW, Antoine JC, Brashear HR, et al. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on Paraneoplastic Neurological Disease, October 22-23, 1994, Rotterdam, The Netherlands. Neurology 1995;45:1937-41.
3. Furneaux HM, Rosenblum MK, Dalmau J, et al. Selective expression of Purkinje cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990;322:1844-51.
4. Darnell RB. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol 2004;61:30-2.
5. Graus FR, Delattre J-Y, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40.